IP Library Assignment 022460/0626
Patent Assignment
Reel/Frame 022460/0626

Assignment of Assignor's Interest

Recorded: 2009-03-30 Pages: 5
Assignor
NPS ALLELIX CORP.
Executed: 2008-12-23
Assignee
NPS PHARMACEUTICALS, INC.
550 HILLS DRIVE. 3RD FLOOR, BEDMINSTER, NEW JERSEY, 07921
Covered Properties (23)
Kainate-Binding, Human Cns Receptors of the EAA2 Family
Patent: 5,494,792 →
Application: 08/091,569 →
Ampa-Binding Human GLUR1 Receptors
Patent: 5,610,032 →
Application: 08/254,573 →
Bicyclic Nonane and Decane Compounds Having Dopamine Receptor Affinity
Patent: 5,576,314 →
Application: 08/354,906 →
Dopamine Receptor Ligands
Patent: 5,538,965 →
Application: 08/355,297 →
Kainate-Binding Human Cns Receptors of the EAA1 Family
Patent: 5,616,481 →
Application: 08/416,523 →
Promoters for Gene Expression
Patent: 5,629,205 →
Application: 08/445,133 →
Kainate-Binding, Human Cns Receptors of the EAA3 Family
Patent: 6,018,023 →
Application: 08/487,691 →
Dopamine Receptor Ligands
Patent: 5,798,350 →
Application: 08/642,264 →
Benzyl-Substituted Compounds Having Dopamine Receptor Affinity
Patent: 5,814,628 →
Application: 08/762,984 →
Kainate-Binding Human Cns Receptors of the EAA1 Family
Patent: 6,013,768 →
Application: 08/789,478 →
N- Methyl Piperazine Compounds Having Dopamine Receptor Affinity
Patent: 5,968,478 →
Application: 08/948,051 →
Dopamine Receptor Ligands
Patent: 6,103,715 →
Application: 09/139,715 →
Cloned Glucagon-Like Peptide-2 Receptors
Patent: 7,473,537 →
Application: 09/331,127 →
Peripheral Nervous System Specific Sodium Channels
Patent: 6,703,486 →
Application: 09/457,571 →
Publication: US 2003/0092645
Glucagon-Like Peptide-2 Analogs
Patent: 7,781,401 →
Application: 10/293,941 →
Publication: US 2003/0162703
Methods Useful in the Treatment of Bone Resorption Diseases
Patent: 7,018,982 →
Application: 10/389,797 →
Publication: US 2003/0162716
Azaindoles Having Serotonin Receptor Affinity
Patent: 6,916,818 →
Application: 10/739,302 →
Publication: US 2004/0132734
Pyromechanical Cutting Element
Patent: 7,222,561 →
Application: 10/768,698 →
Publication: US 2004/0221638
Stabilized formulation of parathyroid hormone
Application: 10/890,520 →
Publication: US 2005/0032698
Method for treating bone loss using parathyroid hormone
Application: 10/986,000 →
Publication: US 2005/0119183
Azaindoles Having Serotonin Receptor Affinity
Patent: 7,268,127 →
Application: 11/165,122 →
Publication: US 2005/0239788
Pharmaceutical for treatment of neurological and neuropsychiatric disorders
Application: 11/259,583 →
Publication: US 2006/0287298
Methods Useful in the Treatment of Bone Resorption Diseases
Patent: 7,507,715 →
Application: 11/305,339 →
Publication: US 2006/0211613
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 4, 2004
From: BREDE, UWE; KORDEL, GERHARD; KNAUSS, JURGEN; MEISINGER, REINHOLD
To: DYNAMIT NOBEL AIS GMBH
Reel/Frame 015853/0048 →
Assignment of Assignor's Interest Oct 21, 2004
From: DAY, DAVID; SENEVIRATNE, ANANDA; TONEY, KAREN
To: NPS PHARMACEUTICALS, INC.; NPS ALLELIX CORP.
Reel/Frame 015909/0442 →
Assignment of Assignor's Interest Feb 8, 2005
From: WELLS, DAVID; FOX, JOHN
To: NPS ALLELIX CORP.; NPS PHARMACEUTICALS, INC.
Reel/Frame 016238/0432 →
Articles of Arrangement Oct 15, 2007
From: ALLELIX BIOPHARMACEUTICALS, INC.
To: NPS ALLELIX CORP.
Reel/Frame 019963/0517 →
Assignment of Assignor's Interest Aug 7, 2008
From: ALLELIX NEUROSCIENCE, INC.
To: NPS PHARMACEUTICALS, INC.
Reel/Frame 021339/0966 →
Assignment of Assignor's Interest Apr 14, 2011
From: DELPHI TECHNOLOGIES, INC.
To: AUTOLIV DEVELOPMENT AB
Reel/Frame 026125/0779 →
Assignment of Assignor's Interest May 31, 2011
From: MG AIS GMBH AUTOMOTIVE IGNITIONS SYSTEMS I. L
To: DELPHI TECHNOLOGIES, INC.
Reel/Frame 026363/0880 →
Security Agreement Dec 20, 2013
From: NPS PHARMACEUTICALS, INC.
To: DRUG ROYALTY L.P. 3
Reel/Frame 031866/0539 →